A Study to Evaluate 9MW2821 Versus Chemotherapy in Subjects With Previously Treated Locally Advanced or Metastatic Urothelial Cancer

NCT06196736 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

432

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Urothelial Carcinoma

Interventions

DRUG: 9MW2821
DRUG: Chemotherapy

Sponsor

Mabwell (Shanghai) Bioscience Co., Ltd.